2021 Annual Meeting | C93 - Hot Topics in Clinical Practice: Anti-amyloid Therapy for Alzheimer's Disease

Date Monday 04/19/21

Time 06:00 PM - 07:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Melissa Yu, MD, FAAN

Moderator(s) Meredith Wicklund, MD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should gain knowledge of anti-amyloid therapy mechanisms of action, clinical trial data and considerations for real-world use of these therapies in clinic.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Introductory

Recommended Audience General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
06:00 PM - 06:25 PM EDT	Speaker	Anti-amyloid Therapies: Background and Science Melissa Yu, MD, FAAN
06:25 PM - 06:45 PM EDT	Speaker	Anti-amyloid Therapies: Practical Considerations Katherine Coerver, MD, PhD, FAAN
06:45 PM - 07:00 PM EDT	Q&A	Live Q&A Melissa Yu, MD, FAAN, Katherine Coerver, MD, PhD, FAAN

Faculty Disclosures
Melissa Yu, MD, FAAN	An immediate family member of Dr. Yu has received personal compensation for serving as an employee of CVS/Aetna. The institution of Dr. Yu has received research support from Alzheimer's Association. The institution of Dr. Yu has received research support from Biogen. The institution of Dr. Yu has received research support from Eisai. The institution of Dr. Yu has received research support from Novo Nordisk. The institution of Dr. Yu has received research support from Suven. The institution of Dr. Yu has received research support from AriBio.
Katherine Coerver, MD, PhD, FAAN	Dr. Coerver has received personal compensation for serving as an employee of CenExel. Dr. Coerver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Coerver has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai . Dr. Coerver has received research support from Lilly. Dr. Coerver has received research support from Annovis. Dr. Coerver has received research support from Biogen.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.